Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis
NCT03302806
·
clinicaltrials.gov ↗
COMPLETED
Status
103
Enrollment
OTHER
Sponsor class
Conditions
Progressive Multiple Sclerosis
Interventions
OTHER:
Non interventional Study
Sponsor
Nantes University Hospital